![]() |
|
|
Vol. 284, Issue 1, 222-227, 1998
Department of Pharmacology and Toxicology (T.E.L., J.S.F.),
Robert
C. Byrd Health Sciences Center, West Virginia University, and Pathology
and Physiology Research Branch (L.L.M., J.S.F.), Health Effects
Laboratory Division, National Institute for Occupational Safety and
Health, Morgantown, West Virginia
In this study, we examined the effects of fluticasone propionate (FP)
and pentamidine isethionate (PI) on antigen-induced lung inflammation
and airway hyperreactivity in guinea pigs. Male guinea pigs were
sensitized on days 0 and 14 with 10 µg of ovalbumin (OVA) plus 1 mg
of Al(OH)3. On day 21, animals were challenged with a 2%
OVA aerosol inhalation until they developed pulmonary obstruction.
Animals were treated with aerosol inhalation of FP (2 ml of 0.5 mg/ml,
five consecutive doses at 12-hr intervals with the last dose given 6 hr
before OVA challenge) or PI (30 mg/ml for 30 min 1 hr before OVA
challenge), and control animals received no drug before OVA challenge.
Airway reactivity to methacholine (MCh) was assessed before
sensitization and 18 hr after OVA challenge. At 18 hr after challenge,
histological sections of trachea and lung were examined for eosinophil,
dendritic cell (DC) and macrophage cell densities in the airways. In
control animals, OVA evoked airway hyperreactivity to MCh in
conjunction with pulmonary eosinophilia and increases in DC prevalence
in the trachea and bronchi. Treatment with FP or PI abolished the
OVA-induced hyperresponsiveness and significantly reduced the
OVA-induced increases in eosinophils and DCs in the airways. FP and PI
had no effect on saline-treated animals. Our study indicates that both
inhaled FP and inhaled PI reduce antigen-induced airway hyperreactivity
and pulmonary inflammation in guinea pigs. The results also suggest
that the DC is a target of the anti-inflammatory effects of these drugs in the airways.
This article has been cited by other articles:
![]() |
M. A. Giembycz and M. A. Lindsay Pharmacology of the Eosinophil Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340. [Abstract] [Full Text] [PDF] |
||||